Corline Biomedical Ab Stock Current Valuation
| CLBIO Stock | SEK 9.76 0.16 1.67% |
Valuation analysis of Corline Biomedical helps investors to measure Corline Biomedical's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Fairly Valued
Today
Please note that Corline Biomedical's price fluctuation is somewhat reliable at this time. Calculation of the real value of Corline Biomedical is based on 3 months time horizon. Increasing Corline Biomedical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Corline stock is determined by what a typical buyer is willing to pay for full or partial control of Corline Biomedical AB. Since Corline Biomedical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Corline Stock. However, Corline Biomedical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 9.76 | Real 9.85 | Hype 9.76 | Naive 10.49 |
The intrinsic value of Corline Biomedical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Corline Biomedical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Corline Biomedical AB helps investors to forecast how Corline stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Corline Biomedical more accurately as focusing exclusively on Corline Biomedical's fundamentals will not take into account other important factors: Corline Biomedical AB Company Current Valuation Analysis
Corline Biomedical's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Corline Biomedical Current Valuation | 178.43 M |
Most of Corline Biomedical's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Corline Biomedical AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Corline Biomedical AB has a Current Valuation of 178.43 M. This is 98.76% lower than that of the Healthcare sector and 96.16% lower than that of the Biotechnology industry. The current valuation for all Sweden stocks is 98.93% higher than that of the company.
Corline Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Corline Biomedical's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Corline Biomedical could also be used in its relative valuation, which is a method of valuing Corline Biomedical by comparing valuation metrics of similar companies.Corline Biomedical is currently under evaluation in current valuation category among its peers.
Corline Fundamentals
| Return On Equity | 0.0075 | |||
| Return On Asset | 0.0044 | |||
| Profit Margin | 0.02 % | |||
| Operating Margin | 0.02 % | |||
| Current Valuation | 178.43 M | |||
| Shares Outstanding | 21.49 M | |||
| Shares Owned By Insiders | 54.88 % | |||
| Shares Owned By Institutions | 14.21 % | |||
| Price To Earning | (19.42) X | |||
| Price To Book | 2.20 X | |||
| Price To Sales | 6.44 X | |||
| Revenue | 7.06 M | |||
| Gross Profit | 9.1 M | |||
| EBITDA | (6.88 M) | |||
| Net Income | (6.92 M) | |||
| Cash And Equivalents | 41.63 M | |||
| Cash Per Share | 1.45 X | |||
| Current Ratio | 3.99 X | |||
| Book Value Per Share | 4.38 X | |||
| Cash Flow From Operations | (4.83 M) | |||
| Earnings Per Share | 0.03 X | |||
| Target Price | 29.0 | |||
| Number Of Employees | 10 | |||
| Beta | 0.8 | |||
| Market Capitalization | 203.87 M | |||
| Total Asset | 101.66 M | |||
| Net Asset | 101.66 M |
About Corline Biomedical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Corline Biomedical AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Corline Biomedical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Corline Biomedical AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Corline Stock Analysis
When running Corline Biomedical's price analysis, check to measure Corline Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Corline Biomedical is operating at the current time. Most of Corline Biomedical's value examination focuses on studying past and present price action to predict the probability of Corline Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Corline Biomedical's price. Additionally, you may evaluate how the addition of Corline Biomedical to your portfolios can decrease your overall portfolio volatility.